Transport related air pollution and health impact
The main objective of the EU research project TRANSPHORM was to assess health impacts of transport-related airborne particulate matter (PM). Integrated assessment tools were developed for scales ranging from city to European. The budget was 9 million euro and involved 20 partners from 12 countries.
Transport-related PM emissions were
determined on both global (EU) and urban scales, based on transport
activity data and improved emission factors of ultra-fine particle
number (PN0.1) and mass fractions of PM1, PM2.5 and PM10.
To map transport activities in EU cities, TML developed an urban transport model that holds an increased level of spatial detail compared to state-of-the-art models. The urban transport model forecasts transport activities in European cities up to 2030.
To quantify exposure to airborne PM in urban environments resulting from traffic, road, shipping, rail and aviation, we developed improved and integrated air quality dispersion and exposure models for urban and regional scales. Targeted measurements were conducted in Rotterdam, Helsinki, Oslo, London, Athens and Prague for source apportionment, exposure assessment and model evaluation.
The TRANSPHORM project finally delivered an integrated methodology to assess policies, measures or strategies that reduce health impacts of transport-related PM emissions. The developed tool was used to generate mitigation and adaptation strategies for European cities and to make policy recommendations for the European Commission.
Project website: http://www.transphorm.eu/
European Commission, FP7
University of Hertforshire (project leader - UK), Institute of Physics (LT), URM-UTVAR ROZVOJE HLMESTA PRAHY (CZ), Helmholtz Zentrum München (DE), Terveyden Ja Hyvinvoinnin Laitos (FI), Schweizerisches Tropeninstitut (CH), Ivl Svenska Miljoeinstitutet, (SE), Ilmatieteen Laitos (FI), Deutsches Zentrum für Luft- und Raumfahrt (DE), Danmarks Meteorologiske Insitut (DK), Norsk Institutt for Luftforskning (NO), Meteorologisk Institutt (NO), Universität Stuttgart (DE), TNO (NL), EC - JRC (ES), Imperial College of Science, Technology and Medicine (UK), Karolinska Institutet (SE), Universiteit Utrecht (NL), Institute of Occupational Medicine (UK), Aristotelio Panepistimio Thessalonikis (EL)
Isaak Yperman, Griet De Ceuster, Filip Vanhove, Kris Vanherle, Joko Purwanto, Karel Spitaels
+32 16 74.51.24
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 243406